Cargando…

Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model

PURPOSE: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women of reproductive age and leads to metabolic disorders and infertility. The present study was conducted to investigate the therapeutic effects of curcumin (Cur) encapsulated arginine (Arg) and N-acetyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Mazhar Ali, Maldonado, Martin, Chen, Jianying, Zhong, Ying, Gu, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439717/
https://www.ncbi.nlm.nih.gov/pubmed/34531655
http://dx.doi.org/10.2147/IJN.S302161
_version_ 1783752557375520768
author Raja, Mazhar Ali
Maldonado, Martin
Chen, Jianying
Zhong, Ying
Gu, Jiang
author_facet Raja, Mazhar Ali
Maldonado, Martin
Chen, Jianying
Zhong, Ying
Gu, Jiang
author_sort Raja, Mazhar Ali
collection PubMed
description PURPOSE: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women of reproductive age and leads to metabolic disorders and infertility. The present study was conducted to investigate the therapeutic effects of curcumin (Cur) encapsulated arginine (Arg) and N-acetyl histidine (NAcHis) modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles (NPs). METHODS: In this study, amphiphilic chitosan (CS) conjugate was developed by modification with hydrophilic arginine (Arg) and hydrophobic N-acetyl histidine (NAcHis) group (Arg-CS-NAcHis). The synthesized conjugate was well characterized by FTIR and NMR studies. Self-assembled nanoparticles based on the synthesized conjugate were developed by simple sonication method and characterized for the physicochemical properties of zeta potential, particle size and drug encapsulation. Next, in vitro drug release, cytotoxicity, and cellular uptake studies of the NPs were evaluated. Finally, the developed nanoparticles were examined for their therapeutic potential against estradiol valerate (EV) induced PCOS rats by evaluating hormone level changes and ovarian morphology. RESULTS: The results showed that zeta potential of the nanoparticles was 39.8±2.52 mV and the average size was 200 nm. The in vitro drug release profile showed sustained release pattern. Cytotoxicity and cellular uptake studies also showed preferential effectiveness than free curcumin. Both the biochemical and histopathological studies showed positive effects in reverting the symptoms of PCOS rats to normalcy. CONCLUSION: Curcumin encapsulated arginine and N-acetyl histidine modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles have been successfully developed. The present study suggested that treatment of the nanoparticles might reverse many of the PCOS symptoms. Therefore, these nanoparticles might be used as promising new candidate for delivery of curcumin to treat PCOS.
format Online
Article
Text
id pubmed-8439717
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84397172021-09-15 Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model Raja, Mazhar Ali Maldonado, Martin Chen, Jianying Zhong, Ying Gu, Jiang Int J Nanomedicine Original Research PURPOSE: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women of reproductive age and leads to metabolic disorders and infertility. The present study was conducted to investigate the therapeutic effects of curcumin (Cur) encapsulated arginine (Arg) and N-acetyl histidine (NAcHis) modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles (NPs). METHODS: In this study, amphiphilic chitosan (CS) conjugate was developed by modification with hydrophilic arginine (Arg) and hydrophobic N-acetyl histidine (NAcHis) group (Arg-CS-NAcHis). The synthesized conjugate was well characterized by FTIR and NMR studies. Self-assembled nanoparticles based on the synthesized conjugate were developed by simple sonication method and characterized for the physicochemical properties of zeta potential, particle size and drug encapsulation. Next, in vitro drug release, cytotoxicity, and cellular uptake studies of the NPs were evaluated. Finally, the developed nanoparticles were examined for their therapeutic potential against estradiol valerate (EV) induced PCOS rats by evaluating hormone level changes and ovarian morphology. RESULTS: The results showed that zeta potential of the nanoparticles was 39.8±2.52 mV and the average size was 200 nm. The in vitro drug release profile showed sustained release pattern. Cytotoxicity and cellular uptake studies also showed preferential effectiveness than free curcumin. Both the biochemical and histopathological studies showed positive effects in reverting the symptoms of PCOS rats to normalcy. CONCLUSION: Curcumin encapsulated arginine and N-acetyl histidine modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles have been successfully developed. The present study suggested that treatment of the nanoparticles might reverse many of the PCOS symptoms. Therefore, these nanoparticles might be used as promising new candidate for delivery of curcumin to treat PCOS. Dove 2021-09-10 /pmc/articles/PMC8439717/ /pubmed/34531655 http://dx.doi.org/10.2147/IJN.S302161 Text en © 2021 Raja et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Raja, Mazhar Ali
Maldonado, Martin
Chen, Jianying
Zhong, Ying
Gu, Jiang
Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_full Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_fullStr Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_full_unstemmed Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_short Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_sort development and evaluation of curcumin encapsulated self-assembled nanoparticles as potential remedial treatment for pcos in a female rat model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439717/
https://www.ncbi.nlm.nih.gov/pubmed/34531655
http://dx.doi.org/10.2147/IJN.S302161
work_keys_str_mv AT rajamazharali developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel
AT maldonadomartin developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel
AT chenjianying developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel
AT zhongying developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel
AT gujiang developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel